Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 21, 16:00
Avadel Pharmaceuticals Shareholders Equity (Quarterly) : 98.22M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 98.22M |
| June 30, 2025 | 90.71M |
| March 31, 2025 | 74.07M |
| December 31, 2024 | 73.85M |
| September 30, 2024 | 74.66M |
| June 30, 2024 | 70.29M |
| March 31, 2024 | 78.38M |
| December 31, 2023 | 87.74M |
| September 30, 2023 | 110.15M |
| June 30, 2023 | 143.19M |
| March 31, 2023 | -38.17M |
| December 31, 2022 | -21.14M |
| September 30, 2022 | -12.44M |
| June 30, 2022 | -3.332M |
| March 31, 2022 | 55.23M |
| December 31, 2021 | 78.24M |
| September 30, 2021 | 98.96M |
| June 30, 2021 | 118.88M |
| March 31, 2021 | 136.50M |
| December 31, 2020 | 162.27M |
| September 30, 2020 | 171.20M |
| June 30, 2020 | 182.12M |
| March 31, 2020 | 32.07M |
| December 31, 2019 | -29.20M |
| September 30, 2019 | -26.96M |
| Date | Value |
|---|---|
| June 30, 2019 | -17.78M |
| March 31, 2019 | -9.582M |
| December 31, 2018 | 2.78M |
| September 30, 2018 | 65.74M |
| June 30, 2018 | 78.55M |
| March 31, 2018 | 87.05M |
| December 31, 2017 | 85.58M |
| September 30, 2017 | 96.46M |
| June 30, 2017 | 76.73M |
| March 31, 2017 | 59.08M |
| December 31, 2016 | 42.07M |
| September 30, 2016 | 36.83M |
| June 30, 2016 | 51.14M |
| March 31, 2016 | 69.70M |
| December 31, 2015 | 67.86M |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 22.25M |
| December 31, 2014 | 24.90M |
| September 30, 2014 | 40.05M |
| June 30, 2014 | 57.86M |
| March 31, 2014 | 78.13M |
| December 31, 2013 | -9.512M |
| September 30, 2013 | -15.40M |
| June 30, 2013 | -10.06M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 4.802B |
| Perrigo Co. Plc | 2.516B |
| GH Research Plc | 359.49M |
| Cosmo NV | -- |
| Alkermes Plc | 1.809B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.45M |
| Total Liabilities (Quarterly) | 101.22M |